Biocon Limited is a globally recognized, innovation-led organization that is enabling access to high quality, advanced therapies for diseases that are chronic, where medical needs are largely unmet and treatment costs are high. Our subsidiary Biocon Biologics is engaged in developing high quality, affordable biosimilars aimed at expanding patient access to a cutting-edge class of therapies across the world